MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells

被引:285
作者
Xiong, Binghong [1 ]
Cheng, Yong [1 ]
Ma, Li [2 ]
Zhang, Caiquan [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Chongqing 400016, Peoples R China
[2] Chongqing Huaxi Hosp, Dept Internal Med, Chongqing 400054, Peoples R China
关键词
colorectal cancer; microRNA-21; phosphatase and tensin homologue; phosphorylated AKT; matrix metalloproteinase-9; TUMOR-SUPPRESSOR GENE; MICRORNA-21; TARGETS; HUMAN CHOLANGIOCARCINOMA; TISSUE INHIBITOR; GASTRIC-CANCER; EXPRESSION; INVASION; PROLIFERATION; MIRNAS; GROWTH;
D O I
10.3892/ijo.2012.1707
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The aim of this study was to determine a role of microRNA-21 (miR-21) in colorectal cancer (CRC) and to elucidate the regulation of phosphatase and tensin homologue (PTEN) gene by miR-21. MiR-21 expression was investigated in 30 CRC samples and five CRC cell lines. In this study, we show that the expression of miR-21 was overexpressed in CRC compared with adenomas and normal tissues. Patients with poor differentiation, lymph node metastasis and advanced TNM stage showed significantly high expression of miR-21. Inhibition of miR-21 in the HCT116 cell line reduced cellular proliferation, migration and invasion, induced apoptosis and inhibited cell cycle progression. The PTEN protein levels in CRC tissues and cells had an inverse correlation with miR-21 expression. Anti-miR-21-transfected cells increased PTEN protein expression without changing the PTEN mRNA level and increased a luciferase-reporter activity. MiR-21 targets PTEN at the posttranscriptional level and regulates cell proliferation and invasion in CRC. It may serve as a novel therapeutic target in CRC.
引用
收藏
页码:219 / 228
页数:10
相关论文
共 66 条
[1]
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer [J].
Asangani, I. A. ;
Rasheed, S. A. K. ;
Nikolova, D. A. ;
Leupold, J. H. ;
Colburn, N. H. ;
Post, S. ;
Allgayer, H. .
ONCOGENE, 2008, 27 (15) :2128-2136
[2]
Oncogenic PI3K deregulates transcription and translation [J].
Bader, AG ;
Kang, SY ;
Zhao, L ;
Vogt, PK .
NATURE REVIEWS CANCER, 2005, 5 (12) :921-929
[3]
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells [J].
Chan, JA ;
Krichevsky, AM ;
Kosik, KS .
CANCER RESEARCH, 2005, 65 (14) :6029-6033
[4]
MicroRNA-21 and PDCD4 expression in colorectal cancer [J].
Chang, K. H. ;
Miller, N. ;
Kheirelseid, E. A. H. ;
Ingoldsby, H. ;
Hennessy, E. ;
Curran, C. E. ;
Curran, S. ;
Smith, M. J. ;
Regan, M. ;
McAnena, O. J. ;
Kerin, M. J. .
EJSO, 2011, 37 (07) :597-603
[5]
Real-time quantification of microRNAs by stem-loop RT-PCR [J].
Chen, CF ;
Ridzon, DA ;
Broomer, AJ ;
Zhou, ZH ;
Lee, DH ;
Nguyen, JT ;
Barbisin, M ;
Xu, NL ;
Mahuvakar, VR ;
Andersen, MR ;
Lao, KQ ;
Livak, KJ ;
Guegler, KJ .
NUCLEIC ACIDS RESEARCH, 2005, 33 (20) :e179.1-e179.9
[6]
MicroRNAs modulate hematopoietic lineage differentiation [J].
Chen, CZ ;
Li, L ;
Lodish, HF ;
Bartel, DP .
SCIENCE, 2004, 303 (5654) :83-86
[7]
Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis [J].
Cheng, AM ;
Byrom, MW ;
Shelton, J ;
Ford, LP .
NUCLEIC ACIDS RESEARCH, 2005, 33 (04) :1290-1297
[8]
Detection and characterization of placental MicroRNAs in maternal plasma [J].
Chim, Stephen S. C. ;
Shing, Tristan K. F. ;
Hung, Emily C. W. ;
Leung, Tak-yeung ;
Lau, Tze-kin ;
Chiu, Rossa W. K. ;
Lo, Y. M. Dennis .
CLINICAL CHEMISTRY, 2008, 54 (03) :482-490
[9]
MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy [J].
Cho, William C. S. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (08) :1273-1281
[10]
MicroRNAs in cancer - from research to therapy [J].
Cho, William C. S. .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2010, 1805 (02) :209-217